Sintx Technologies (SINT) Preferred Shares (2016 - 2026)
Sintx Technologies (SINT) posted Preferred Shares of $130.0 million for Q2 2026, little changed on a QoQ basis from $130.0 million in Q4 2025.
Powered by 
Analysis
Sintx Technologies (SINT) Preferred Shares (2016 - 2026) Analysis & Trends
Sintx Technologies has reported Preferred Shares for 4 years, with the latest figure at $130.0 million in Q2 2026.
- On a quarterly basis, Preferred Shares changed N/A year-over-year to $130.0 million in Q2 2026; TTM through Jun 2026 was $130.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $130.0 million, changed N/A from the prior year.
- Preferred Shares was $130.0 million for Q2 2026 at Sintx Technologies, roughly flat from $130.0 million in the prior quarter.
- The five-year high for Preferred Shares was $130.0 million in Q4 2025, with the low at $130.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Sintx Technologies | 8.73 Mn | 8.73 Mn | - | 130.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 130.00 Mn |
| Dec 31, 2025 | 130.00 Mn |
| Sep 30, 2017 | 130.00 Mn |
| Jun 30, 2017 | 130.00 Mn |
| Dec 31, 2016 | 130.00 Mn |